Topics
Glioblastoma | Treatment | Targeted therapy | Sacituzumab Govitecan
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Sacituzumab Govitecan
Balinda HU, Kelly WJ, Kaklamani VG, Lathrop KI, Canola MM,
Ghamasaee P, Sareddy GR, Michalek J, Gilbert AR, Surapaneni P,
Tiziani S, Pandey R, Chiou J, Lodi A, Floyd JR 2nd, Brenner AJ.
Sacituzumab Govitecan in patients with
breast cancer
brain metastases and recurrent glioblastoma: a phase 0
window-of-opportunity trial.
Nat
Commun. 2024 Aug 7;15(1):6707. doi:
10.1038/s41467-024-50558-9. PMID:
39112464. Interventional study. ˍ